Showing results (431-440 of 679) with videos related to
Sort By:
Pageof 68
Neoplasia (New York, N.Y.)|December 3, 2008
Bmi1 is required for Hedgehog pathway-driven medulloblastoma expansionLowell Evan Michael, Bart A Westerman, Alexandre N Ermilov, et al.Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|May 11, 2019
Dedifferentiation in SDH-Deficient Gastrointestinal Stromal Tumor: A Report With Histologic, Immunophenotypic, and Molecular CharacterizationFaizan Malik, Teresa Santiago, Armita Bahrami, et al.Plos One|June 14, 2013
Motivational disturbances and effects of L-dopa administration in neurofibromatosis-1 model miceDavid F Wozniak, Kelly A Diggs-Andrews, Sara Conyers, et al.Neurobiology of Disease|February 5, 2013
ABCA1 influences neuroinflammation and neuronal deathJoanna M Karasinska, Willeke de Haan, Sonia Franciosi, et al.Journal of the American Medical Informatics Association : JAMIA|September 18, 2025
Comparison of rule- and large language model-based phenotype extraction from clinical notes for neurofibromatosis type 1Levi Kaster, Ethan Hillis, Inez Y Oh, et al.Elife|January 30, 2024
SRF-deficient astrocytes provide neuroprotection in mouse models of excitotoxicity and neurodegenerationSurya Chandra Rao Thumu, Monika Jain, Sumitha Soman, et al.Oncotarget|May 20, 2017
The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formationAnne C Solga, Joseph A Toonen, Yuan Pan, et al.Pediatric Blood & Cancer|May 23, 2014
Sirolimus for non-progressive NF1-associated plexiform neurofibromas: an NF clinical trials consortium phase II studyBrian Weiss, Brigitte C Widemann, Pamela Wolters, et al.Neuro-Oncology Advances|May 20, 2022
Phase II study of intravenous etoposide in patients with relapsed ependymoma (CNS 2001 04)John R Apps, Shanna Maycock, David W Ellison, et al.Cancer Cell|February 21, 2012
A mouse model of the most aggressive subgroup of human medulloblastomaDaisuke Kawauchi, Giles Robinson, Tamar Uziel, et al.Pageof 68